Home LiteratureArticle Details
PMID: 33790621 Published · epublish English Journal Article

FUT7 Promotes the Epithelial-Mesenchymal Transition and Immune Infiltration in Bladder Urothelial Carcinoma.

Journal of inflammation research ·Vol. 14 ·2021-00-00 ·Pages 1069-1084

Liu M, Zheng Q, Chen S, Liu J, Li S

Abstract

Bladder urothelial carcinoma (BLCA) is one of the most frequently appearing, lethal and aggressive malignancies of the genitourinary system with growing morbidity and mortality, which affects human health seriously. Protein glycosylation, catalyzed by specific glycosyltransferase, has been found to be abnormal in several diseases, especially cancer. Fucosyltransferase VII (FUT7), one of the fucosyltransferases, was observed abnormally expressed in various cancers, however, the role of FUT7 in BLCA, and the association between its expression and clinical outcomes or immune infiltration remains unclear. FUT7 expression in BLCA was analyzed in Oncomine database, which was further confirmed with immunohistochemistry and ELISA. The prognostic value of FUT7 for BLCA was evaluated with PrognoScan database, and its genetic alteration was examined in cBioPortal database. The proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) changes of bladder cancer cells after FUT7 siRNA or cDNA transfection were determined by CCK8, colony formation, transwell and Western blot, respectively. The correlation between FUT7 expression and immune infiltration levels was analyzed in TIMER and TISIDB databases, and the methylation level of FUT7 was detected in UALCAN database. The results showed that the expression of FUT7 was increased in BLCA, and patients with high FUT7 level were predicted to have lower overall survival and disease-specific survival rates, which were not influenced by FUT7 genetic alterations. Downregulation FUT7 inhibited the proliferation, migration, invasion and EMT of bladder cancer cells, whereas upregulation of FUT7 showed the opposite effects. We found that FUT7 was positively correlated with immune cell infiltration levels (CD8+ T cells, CD4+T cells, macrophage, neutrophil and dendritic cells), and also the expression of gene markers of immune cells. The negative correlation between FUT7 expression and FUT7 methylation level was observed, among which FUT7 expression was positively correlated with the abundance of 28 kinds of tumor-infiltrating lymphocytes (TILs), while FUT7 methylation level was negatively correlated with TILs. Altogether, these findings suggested that FUT7 possessed the potential to serve as a detection biomarker or immunotherapeutic target for BLCA.

Keywords
EMT FUT7 bladder urothelial carcinoma diagnosis immune infiltration prognosis
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Liu Mulin ORCID
Department of Clinical Laboratory, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, 116011, People's Republic of China.
Zheng Qin
Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, Liaoning Province, 116044, People's Republic of China.
Chen Siyi
Department of Biochemistry and Molecular Biology, Dalian Medical University, Dalian, Liaoning Province, 116044, People's Republic of China.
Liu Jiwei
Department of Oncology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, 116011, People's Republic of China.
Li Shijun
Department of Clinical Laboratory, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning Province, 116011, People's Republic of China.
Conflict of Interest

The authors declare no conflict of interests.

References (52)
52 references, click to expand
  1. Detecting substrate glycans of fucosyltransferases with fluorophore-conjugated fucose and methods for glycan electrophoresis.
    Glycobiology. 2020 Dec 9;30(12):970-980 PMID: 32248235
  2. Fucosyltransferase 4 and 7 mediates adhesion of non-small cell lung cancer cells to brain-derived endothelial cells and results in modification of the blood-brain-barrier: in vitro investigation of CD15 and CD15s in lung-to-brain metastasis.
    J Neurooncol. 2019 Jul;143(3):405-415 PMID: 31104223
  3. B Cells and Tertiary Lymphoid Structures Influence Survival in Lung Cancer Patients with Resectable Tumors.
    Cancers (Basel). 2020 Sep 16;12(9): PMID: 32947928
  4. Role of glycosylation in TGF-β signaling and epithelial-to-mesenchymal transition in cancer.
    Protein Cell. 2021 Feb;12(2):89-106 PMID: 32583064
  5. Competitive glucose metabolism as a target to boost bladder cancer immunotherapy.
    Nat Rev Urol. 2020 Feb;17(2):77-106 PMID: 31953517
  6. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance.
    Int J Mol Sci. 2020 Sep 18;21(18): PMID: 32962159
  7. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.
    Eur Urol. 2021 Jan;79(1):82-104 PMID: 32360052
  8. Bladder cancer.
    Nat Rev Dis Primers. 2017 Apr 13;3:17022 PMID: 28406148
  9. Fucosyltransferase 4 shapes oncogenic glycoproteome to drive metastasis of lung adenocarcinoma.
    EBioMedicine. 2020 Jul;57:102846 PMID: 32629386
  10. Aberrant glycosylation patterns on cancer cells: Therapeutic opportunities for glycodendrimers/metallodendrimers oncology.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jan;13(1):e1659 PMID: 32776710
  11. α-1,3-Fucosyltransferase-VII siRNA inhibits the expression of SLex and hepatocarcinoma cell proliferation.
    Int J Mol Med. 2018 Nov;42(5):2700-2708 PMID: 30226570
  12. Reduced mannosidase MAN1A1 expression leads to aberrant N-glycosylation and impaired survival in breast cancer.
    Br J Cancer. 2018 Mar 20;118(6):847-856 PMID: 29381688
  13. Study on metastasis inhibition of Kejinyan decoction on lung cancer by affecting tumor microenvironment.
    Cancer Cell Int. 2020 Sep 14;20:451 PMID: 32943999
  14. CtBP1 promotes tumour-associated macrophage infiltration and progression in non-small-cell lung cancer.
    J Cell Mol Med. 2020 Oct;24(19):11445-11456 PMID: 32910558
  15. MicroRNA-200c impairs uterine receptivity formation by targeting FUT4 and α1,3-fucosylation.
    Cell Death Differ. 2017 Dec;24(12):2161-2172 PMID: 28914881
  16. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions.
    Urol Oncol. 2021 Jan;39(1):41-51 PMID: 32919875
  17. N-Glycome changes reflecting resistance to platinum-based chemotherapy in ovarian cancer.
    J Proteomics. 2021 Jan 6;230:103964 PMID: 32898699
  18. Altered N-glycosylation profiles as potential biomarkers and drug targets in diabetes.
    FEBS Lett. 2019 Jul;593(13):1598-1615 PMID: 31215021
  19. Endoscopic Molecular Imaging plus Photoimmunotherapy: A New Strategy for Monitoring and Treatment of Bladder Cancer.
    Mol Ther Oncolytics. 2020 Aug 05;18:409-418 PMID: 32913890
  20. CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer.
    Int J Mol Sci. 2020 Sep 22;21(18): PMID: 32971948
  21. Identification of DNA methylation signatures associated with poor outcome in lower-risk Stage, Size, Grade and Necrosis (SSIGN) score clear cell renal cell cancer.
    Clin Epigenetics. 2021 Jan 18;13(1):12 PMID: 33461589
  22. Imprinting of Skin/Inflammation Homing in CD4+ T Cells Is Controlled by DNA Methylation within the Fucosyltransferase 7 Gene.
    J Immunol. 2016 Oct 15;197(8):3406-3414 PMID: 27591321
  23. Suppression of G6PD induces the expression and bisecting GlcNAc-branched N-glycosylation of E-Cadherin to block epithelial-mesenchymal transition and lymphatic metastasis.
    Br J Cancer. 2020 Oct;123(8):1315-1325 PMID: 32719549
  24. N-Glycoproteomic Profiling Reveals Alteration In Extracellular Matrix Organization In Non-Type Bladder Carcinoma.
    J Clin Med. 2019 Aug 24;8(9): PMID: 31450586
  25. Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44.
    Cancer Manag Res. 2020 Jan 22;12:511-522 PMID: 32158257
  26. Treatment of muscle-invasive and advanced bladder cancer in 2020.
    CA Cancer J Clin. 2020 Sep;70(5):404-423 PMID: 32767764
  27. GALNT1-Mediated Glycosylation and Activation of Sonic Hedgehog Signaling Maintains the Self-Renewal and Tumor-Initiating Capacity of Bladder Cancer Stem Cells.
    Cancer Res. 2016 Mar 1;76(5):1273-83 PMID: 26676748
  28. Elevated GALNT10 expression identifies immunosuppressive microenvironment and dismal prognosis of patients with high grade serous ovarian cancer.
    Cancer Immunol Immunother. 2020 Feb;69(2):175-187 PMID: 31853576
  29. Fucosyltransferase VII promotes proliferation via the EGFR/AKT/mTOR pathway in A549 cells.
    Onco Targets Ther. 2017 Aug 07;10:3971-3978 PMID: 28860805
  30. Prognostic and Predictive Value of Tumor-Infiltrating Immune Cells in Urothelial Cancer of the Bladder.
    Cancers (Basel). 2020 Sep 21;12(9): PMID: 32967190
  31. Targeting cancer metastasis with antibody therapeutics.
    Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jan 18;:e1698 PMID: 33463090
  32. Cancer statistics in China, 2015.
    CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32 PMID: 26808342
  33. Prognostic value of the FUT family in acute myeloid leukemia.
    Cancer Gene Ther. 2020 Feb;27(1-2):70-80 PMID: 31209266
  34. Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers.
    Cancer Discov. 2020 Dec;10(12):1872-1893 PMID: 32938586
  35. POFUT1 mRNA expression as an independent prognostic parameter in muscle-invasive bladder cancer.
    Transl Oncol. 2021 Jan;14(1):100900 PMID: 33099185
  36. Macrophage-secreted MMP9 induces mesenchymal transition in pancreatic cancer cells via PAR1 activation.
    Cell Oncol (Dordr). 2020 Dec;43(6):1161-1174 PMID: 32809114
  37. Role of tyrosine kinases in bladder cancer progression: an overview.
    Cell Commun Signal. 2020 Aug 14;18(1):127 PMID: 32795296
  38. Enzymatic glycosylation involving fluorinated carbohydrates.
    Org Biomol Chem. 2020 May 13;18(18):3423-3451 PMID: 32319497
  39. Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation.
    Cell Death Dis. 2020 Oct 16;11(10):871 PMID: 33067424
  40. Glycosylation in the Tumor Microenvironment: Implications for Tumor Angiogenesis and Metastasis.
    Cells. 2019 Jun 05;8(6): PMID: 31195728
  41. The DDX39B/FUT3/TGFβR-I axis promotes tumor metastasis and EMT in colorectal cancer.
    Cell Death Dis. 2021 Jan 12;12(1):74 PMID: 33436563
  42. CLDN10 associated with immune infiltration is a novel prognostic biomarker for clear cell renal cell carcinoma.
    Epigenomics. 2021 Jan;13(1):31-45 PMID: 33203244
  43. Protein glycosylation in head and neck cancers: From diagnosis to treatment.
    Biochim Biophys Acta Rev Cancer. 2020 Dec;1874(2):188422 PMID: 32853734
  44. Colon-specific immune microenvironment regulates cancer progression versus rejection.
    Oncoimmunology. 2020 Jul 12;9(1):1790125 PMID: 32923152
  45. Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer.
    Nat Commun. 2020 Dec 1;11(1):6139 PMID: 33262351
  46. Enhanced lipid biosynthesis in human tumor-induced macrophages contributes to their protumoral characteristics.
    J Immunother Cancer. 2020 Sep;8(2): PMID: 32943450
  47. Intratumoral CCR5+ neutrophils identify immunogenic subtype muscle-invasive bladder cancer with favorable prognosis and therapeutic responses.
    Oncoimmunology. 2020 Aug 12;9(1):1802176 PMID: 32923162
  48. Baicalin promotes embryo adhesion and implantation by upregulating fucosyltransferase IV (FUT4) via Wnt/beta-catenin signaling pathway.
    FEBS Lett. 2015 May 8;589(11):1225-33 PMID: 25896022
  49. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.
    Nat Rev Cancer. 2015 Jan;15(1):25-41 PMID: 25533674
  50. Prognostic significance of immune landscape in tumour microenvironment of endometrial cancer.
    J Cell Mol Med. 2020 Jul;24(14):7767-7777 PMID: 32424934
  51. FUT7 promotes the malignant transformation of follicular thyroid carcinoma through α1,3-fucosylation of EGF receptor.
    Exp Cell Res. 2020 Aug 15;393(2):112095 PMID: 32442537
  52. Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.
    Eur Urol. 2017 Mar;71(3):462-475 PMID: 27375033
Full Text / Full Text
PMC full text available locally, click to read

Loading full text...

Article Info
Journal
Journal of inflammation research
Abbr.
J Inflamm Res
ISSN
1178-7031
Published
2021-00-00
Epub
2021-00-25
Pages
1069-1084
Language
English
Region
New Zealand
NLM ID
101512684
PMCID
PMC8007615
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com